Index of reports
> Cases with Bronchopulmonary Aspergillosis (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Amphotericin B where reactions include bronchopulmonary aspergillosis. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Amphotericin B side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-11
Patient: 43 year old male
Reactions: Liver Injury, Bronchopulmonary Aspergillosis, Dyspnoea, Haemoptysis, Device Related Infection, Death, Renal Failure, Sepsis Syndrome, Renal Impairment, Cardio-Respiratory Arrest, Cardiac Failure, Respiratory Failure, Hallucination, Visual, Neutropenia, Mycobacterium Fortuitum Infection, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ciprofloxacin HCL
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Clarithromycin
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Oseltamivir
Dosage: 75 mg, 2x/day
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Immunosuppression
Amphotericin B
Indication: Aspergillosis
Prednisolone
Dosage: 60 mg, unk
Indication: Immunosuppression
Ciprofloxacin HCL
Dosage: 60 mg
Voriconazole
Dosage: unk
Indication: Aspergillosis
Teicoplanin
Dosage: 400 mg, 1x/day
Indication: Product Used FOR Unknown Indication
Meropenem
Dosage: 1 g, 2x/day
Indication: Product Used FOR Unknown Indication
Possible Amphotericin B side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) on 2012-06-08
Patient: 43 year old male
Reactions: Liver Injury, Bronchopulmonary Aspergillosis, Neutropenic Sepsis, Cholestasis, H1n1 Influenza, Haemodialysis, Cardio-Respiratory Arrest, Hallucination, Visual, Cardiac Failure, Mycobacterium Fortuitum Infection, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ciprofloxacin
Dosage: 1000 mg (500 mg, 2 in 1 d),
Indication: Mycobacterium Fortuitum Infection
Clarithromycin
Dosage: 1000 mg (500 mg, 2 in 1 d),
Indication: Mycobacterium Fortuitum Infection
Teicoplanin (Teicoplanin)
Dosage: 400 mg (400 mg, 1 in 1 d), parenteral
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 100 mg (100 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Immunosuppression
Oseltamivir Phosphate
Dosage: 150 mg (75 mg, 2 in 1 d), parenteral
Indication: Product Used FOR Unknown Indication
Prednisolone
Dosage: 60 mg,
Indication: Immunosuppression
Voriconazole
Indication: Aspergillosis
Meropenem
Dosage: 2 gm (1 gm, 2 in 1 d), parenteral
Indication: Product Used FOR Unknown Indication
Amphotericin B
Indication: Aspergillosis
Possible Amphotericin B side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) on 2012-05-30
Patient: 43 year old male
Reactions: Bronchopulmonary Aspergillosis, Liver Injury, Haemoptysis, Neutropenic Sepsis, Device Related Infection, H1n1 Influenza, Renal Failure, Cardio-Respiratory Arrest, Hallucination, Visual, Cardiac Failure, Respiratory Failure, Mycobacterium Fortuitum Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Teicoplanin (Teicoplanin)
Indication: Product Used FOR Unknown Indication
Voriconazole
Indication: Product Used FOR Unknown Indication
Clarithromycin
Dosage: 1000 mg (500 mg, 2 in 1 d)
Indication: Mycobacterium Fortuitum Infection
Prednisolone
Dosage: 60 mg
Indication: Immunosuppression
Oseltamivir Phosphate
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 100 mg (100 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Immunosuppression
Amphotericin B
Indication: Aspergillosis
Ciprofloxacin
Dosage: 1000 mg (500 mg, 2 in 1 d)
Indication: Mycobacterium Fortuitum Infection
Meropenem
Indication: Product Used FOR Unknown Indication
Possible Amphotericin B side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-30
Patient: 43 year old male
Reactions: Liver Injury, Device Related Infection, Death, Cardio-Respiratory Arrest, Mycobacterium Fortuitum Infection, Bronchopulmonary Aspergillosis, Dyspnoea, Haemoptysis, Sepsis Syndrome, Renal Failure, Renal Impairment, Cardiac Failure, Hallucination, Visual, Respiratory Failure, Neutropenia, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ciprofloxacin HCL
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Prednisolone
Dosage: 60 mg, unk
Indication: Immunosuppression
Oseltamivir
Indication: Product Used FOR Unknown Indication
Teicoplanin
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Immunosuppression
Clarithromycin
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Voriconazole
Dosage: unk
Indication: Aspergillosis
Meropenem
Indication: Product Used FOR Unknown Indication
Amphotericin B
Indication: Aspergillosis
Possible Amphotericin B side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-28
Patient: 43 year old male
Reactions: Bronchopulmonary Aspergillosis, Liver Injury, Renal Failure, Endocarditis Bacterial, Cardiac Failure, Neutropenic Sepsis, H1n1 Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Meropenem
Amikacin
Cyclophosphamide
Administration route: Oral
Indication: Vasculitis
Clarithromycin
Indication: Infection
Amphotericin B
Voriconazole
Prednisolone
Administration route: Oral
Indication: Vasculitis
Ciprofloxacin
Indication: Infection
Teicoplanin
Oseltamivir Phosphate
Possible Amphotericin B side effects in 43 year old female
Reported by a physician from Korea, Republic of on 2012-04-02
Patient: 43 year old female
Reactions: Bronchopulmonary Aspergillosis, Renal Impairment, Pneumonia, Lymphangioleiomyomatosis, Aspergillosis, Asphyxia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Deflazacort
Indication: Lung Transplant
Tacrolimus
Indication: Immunosuppressant Drug Therapy
Amphotericin B
Indication: Bronchopulmonary Aspergillosis
Voriconazole
Indication: Bronchopulmonary Aspergillosis
Mycophenolate Mofetil
Indication: Immunosuppressant Drug Therapy
Itraconazole
Dosage: 400 mg
Indication: Aspergillosis
Fluconazole
Dosage: 50 mg
Indication: Prophylaxis
Mycophenolate Mofetil
Indication: Lung Transplant
Cotrim
Indication: Antibiotic Prophylaxis
Valganciclovir
Indication: Antibiotic Prophylaxis
Voriconazole
Dosage: 150 mg
Indication: Pneumonia
Deflazacort
Dosage: 24 mg
Indication: Immunosuppressant Drug Therapy
Tacrolimus
Indication: Lung Transplant
Amphotericin B
Dosage: 35 mg
Indication: Pneumonia
Possible Amphotericin B side effects in 67 year old female
Reported by a physician from United States on 2012-01-27
Patient: 67 year old female
Reactions: Bronchopulmonary Aspergillosis, Aspergillosis, Pleural Effusion, Condition Aggravated, Cerebral Ischaemia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Sirolimus
Dosage: 1 mg
Indication: Immunosuppressant Drug Therapy
Amphotericin B
Indication: Aspergillosis
Amphotericin B
Indication: Bronchopulmonary Aspergillosis
Prednisone TAB
Dosage: 7.5 mg
Indication: Immunosuppressant Drug Therapy
Tacrolimus
Dosage: 1.5 mg
Voriconazole
Administration route: Oral
Indication: Aspergillosis
Tacrolimus
Dosage: 4 mg
Indication: Immunosuppressant Drug Therapy
Voriconazole
Indication: Bronchopulmonary Aspergillosis
Possible Amphotericin B side effects in 34 year old male
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2011-10-31
Patient: 34 year old male
Reactions: Bronchopulmonary Aspergillosis, Post Procedural Bile Leak, Nephropathy Toxic, Transplant Rejection, Biloma, Hepatic Enzyme Increased
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Fluconazole
Indication: Immunosuppressant Drug Therapy
Methylprednisolone
Dosage: 500 mg
Indication: Immunosuppressant Drug Therapy
Voriconazole
Indication: Bronchopulmonary Aspergillosis
Mycophenolate Mofetil
Indication: Immunosuppressant Drug Therapy
Amphotericin B
Indication: Bronchopulmonary Aspergillosis
|